Literature DB >> 28116709

Measurement of Angiotensin Peptides: HPLC-RIA.

K Bridget Brosnihan1, Mark C Chappell2.   

Abstract

The renin-angiotensin system (RAS) is a complex circulating and tissue-based system. There are multiple pathways for the formation and degradation of peptides. In order to understand the functions of the system, characterization of angiotensin peptides (products and substrates) is important. Radioimmunoassays with the requisite specificity and sensitivity have been developed to allow for the characterization and quantification of circulating and tissue angiotensins. Here, we describe the appropriate methods for collecting the tissue and blood, the extractions steps required to partially purify and remove larger molecular weight-interfering proteins from tissue and plasma, and the radioimmunoassay of three of the peptides of this system (Ang I, Ang II, and Ang-(1-7)), as well as the verification of immunoreactive identity for Ang II and Ang-(1-7) by combined high-performance liquid chromatography-RIA analysis.

Entities:  

Keywords:  Angiotensin I; Angiotensin II; Angiotensin-(1-7); Extraction; HPLC; Homogenization; Radioimmunoassay

Mesh:

Substances:

Year:  2017        PMID: 28116709      PMCID: PMC5490363          DOI: 10.1007/978-1-4939-6625-7_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Opposing actions of angiotensins on angiogenesis.

Authors:  R D Machado; R A Santos; S P Andrade
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

Review 2.  Role of renin-angiotensin system in inflammation, immunity and aging.

Authors:  Luciano S A Capettini; Fabrizio Montecucco; Francois Mach; Nikos Stergiopulos; Robson A S Santos; Rafaela F da Silva
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures.

Authors:  K Kohara; Y Tabuchi; P Senanayake; K B Brosnihan; C M Ferrario
Journal:  Peptides       Date:  1991 Sep-Oct       Impact factor: 3.750

Review 4.  Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Authors:  Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

5.  Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides.

Authors:  M C Chappell; K B Brosnihan; D I Diz; C M Ferrario
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

6.  Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney.

Authors:  Brian M Westwood; Mark C Chappell
Journal:  Peptides       Date:  2012-04-03       Impact factor: 3.750

7.  Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.

Authors:  D J Campbell; A Kladis; A J Valentijn
Journal:  J Cardiovasc Pharmacol       Date:  1995-08       Impact factor: 3.105

8.  Angiotensin(1-7) in the spontaneously hypertensive rat.

Authors:  K Kohara; K B Brosnihan; C M Ferrario
Journal:  Peptides       Date:  1993 Sep-Oct       Impact factor: 3.750

9.  Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7).

Authors:  E Ann Tallant; Michelle A Clark
Journal:  Hypertension       Date:  2003-09-02       Impact factor: 10.190

10.  Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides.

Authors:  J Gregory Modrall; Javid Sadjadi; K Bridget Brosnihan; Patricia E Gallagher; Chun-hua Yu; Gerald L Kramer; Kenneth E Bernstein; Mark C Chappell
Journal:  Hypertension       Date:  2004-02-23       Impact factor: 10.190

View more
  12 in total

1.  Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19.

Authors:  Mauro G Silva; Gerardo R Corradi; Juan I Pérez Duhalde; Myriam Nuñez; Eliana M Cela; Daniel H Gonzales Maglio; Ana Brizzio; Martin R Salazar; Walter G Espeche; Mariela M Gironacci
Journal:  Biomed Pharmacother       Date:  2022-05-27       Impact factor: 7.419

2.  Poor Performance of Angiotensin II Enzyme-Linked Immuno-Sorbent Assays in Mostly Hypertensive Cohort Routinely Screened for Primary Aldosteronism.

Authors:  Agnieszka Łebek-Szatańska; Lucyna Papierska; Piotr Glinicki; Wojciech Zgliczyński
Journal:  Diagnostics (Basel)       Date:  2022-04-30

Review 3.  Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.

Authors:  Matthew A Sparks; Andrew M South; Andrew D Badley; Carissa M Baker-Smith; Daniel Batlle; Biykem Bozkurt; Roberto Cattaneo; Steven D Crowley; Louis J Dell'Italia; Andria L Ford; Kathy Griendling; Susan B Gurley; Scott E Kasner; Joseph A Murray; Karl A Nath; Marc A Pfeffer; Janani Rangaswami; W Robert Taylor; Vesna D Garovic
Journal:  Hypertension       Date:  2020-09-28       Impact factor: 10.190

4.  Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent.

Authors:  Peter Serfozo; Jan Wysocki; Gvantca Gulua; Arndt Schulze; Minghao Ye; Pan Liu; Jing Jin; Michael Bader; Timo Myöhänen; J Arturo García-Horsman; Daniel Batlle
Journal:  Hypertension       Date:  2019-12-02       Impact factor: 10.190

5.  Mas receptor is translocated to the nucleus upon agonist stimulation in brainstem neurons from spontaneously hypertensive rats but not normotensive rats.

Authors:  Flavia M Cerniello; Mauro G Silva; Oscar A Carretero; Mariela M Gironacci
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

6.  Angiotensin (1-12) in Humans With Normal Blood Pressure and Primary Hypertension.

Authors:  Carlos M Ferrario; Seethalakshmi R Iyer; John C Burnett; Sarfaraz Ahmad; Kendra N Wright; Jessica L VonCannon; Amit Saha; Leanne Groban
Journal:  Hypertension       Date:  2021-01-19       Impact factor: 10.190

7.  A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure.

Authors:  D Clark Files; Kevin W Gibbs; Christopher L Schaich; Sean P Collins; TanYa M Gwathmey; Jonathan D Casey; Wesley H Self; Mark C Chappell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

8.  Molecularly imprinted spongy columns for Angiotensin(II) recognition from human serum.

Authors:  Mehtap Yıldırım; Gözde Baydemir Peşint
Journal:  Biotechnol Prog       Date:  2020-12-30

9.  Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1-7) and Angiotensin II in Human Plasma.

Authors:  Mark C Chappell; Nancy T Pirro; Andrew M South; TanYa M Gwathmey
Journal:  Hypertension       Date:  2021-01-05       Impact factor: 10.190

10.  Newly developed radioimmunoassay for Human Angiotensin-(1-12) measurements in plasma and urine.

Authors:  Sarfaraz Ahmad; Henry A Punzi; Kendra N Wright; Leanne Groban; Carlos M Ferrario
Journal:  Mol Cell Endocrinol       Date:  2021-03-30       Impact factor: 4.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.